Details of the Drug-Related molecule(s) Interaction Atlas

General Information of Drug (ID: DMLY1NQ)

Drug Name

IMB-101 Drug Info

Indication

Disease Entry	ICD 11	Status	REF
Coronary artery disease	BA80	Phase 2	[1]

Cross-matching ID

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Download the Complete Interaction Atlas for Visualization in Cytoscape

Drug Therapeutic Target (DTT)

DTT Name	DTT ID	UniProt ID	MOA	REF
3-ketoacyl-CoA thiolase, mitochondrial (ACAA2)	TTM3F49	THIM_HUMAN	Inhibitor	[2]

------------------------------------------------------------------------------------

References

1	ClinicalTrials.gov (NCT04826172) A Randomized, Double-Blind, Placebo-Controlled, Exploratory Study on the Safety, Tolerability, and Pharmacodynamics of IMB-1018972 in Subjects With Angina Due to Obstructive Coronary Artery Disease. U.S.National Institutes of Health.
2	Clinical pipeline report, company report or official report of Imbria Pharmaceuticals